ser64

ser64 Pro+

Chemical and materials science companies like Cabot are going to be key players over the next decade in providing core resources to manufacturing, infrastructure, food supply chain, and energy independence for the US and other western countries. Additionally, Cabot looks ripe for a technical breakout at current levels - MACD bull crossover, RSI bull crossover,...

ser64 Pro+

One of the biggest fertilizer producers in the world, CF is well-poised to take advantage of the demand surge coming as planting seasons in the northern hemisphere start for the next quarter and shortages in ammonia, nitrates, and other fertilizer base materials ramp due to the Russia/Ukraine conflict. All that said, it looks like things have gotten too hot and...

ser64 Pro+

I'm using this as a guide to play earnings. I think earnings are priced in after the move seen in conjunction with with ENPH. Its possible the surprise is enough to move the entire channel up with a bottom around current levels but I think we're more likely to see some guidance around margins being squeezed so we will probably have to wait a few quarters to retest...

ser64 Pro+

Technicals don't add up for buying the dip yet. Wait for a test of $121 support and earnings results to confirm bounce or continuation to downside.

ser64 Pro+

Looks like BA is gonna bounce off the -2SD line again and go back to the +2 SD line for a PT of $300

ser64 Pro+

Stock just failed at the 105 resistance, so it'll probably fall to support around 90. Then you can go long between 80 and 90 and hold up to 130ish. Assuming the Boeing 737 Max issues are resolved shortly, you'll see a quick move up.

ser64 Pro+

Same pattern failing off fib, bouncing off fib on the way down, and moving up >30%.

ser64 Pro+

see chart

ser64 Pro+

See chart

ser64 Pro+

See chart

ser64 Pro+

Solid fundamentals, good dividend, excess capital. This will be a dividend grower in the future. Looking to start with a 50% position at the denoted BZs.

ser64 Pro+

$20-25

ser64 Pro+

As in January when MOTS had a patent granted by the US and got clearance from the EU, this time they got FDA clearance for their solution for Upper GI Endoscopies. We are seeing the same magnitude of candles on the 2h and 4h charts. I think for a scalp, if you can get in below 1.5, you can hit 1.62 before a pull back in the first few minutes. Otherwise, I think...

ser64 Pro+

Wait for confirmation here (need a close above $2 or a move above $2.25). Keep your stops tight and move them up as the stock goes.

ser64 Pro+

If we can't hold the fib level we're sitting on, we could fall to $43k and then $40k

ser64 Pro+

NNDM spent pennies on the DeepCube acquisition but at least now investors can see they are serious about using the capital they raised over the last year for acquisitions and that they probably won't overpay for companies. See chart for swing trade levels. I'm long the stock.

ser64 Pro+

see chart

ser64 Pro+

Still long the stock but without some catalyst, NNDM will move flat to down for the foreseeable future.